Concepedia

Edwin McElroy

EM

Statistics

Publications

6

Citations

263

H-Index

6

Active since

1998

Affiliations

Mayo Clinic(Current)

Edwin McElroy is an author at Mayo Clinic specializing in medicine, cancer pharmacology, and pharmacology.

Publications per year

1998–2021

6

Publications

6

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.

Henry C. Pitot, Edwin McElroy, Joel M. Reid et al. · PubMed · 1999 · 101 citations

, , +13

Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis

Animesh Pardanani, Thomas E. Witzig, Georgene Schroeder et al. · Blood · 2003 · 78 citations · Full text

, , +7

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer

Thomas E. Stinchcombe, Amy H. Peterman, Carrie B. Lee et al. · Journal of Thoracic Oncology · 2011 · 36 citations · Full text

, , +11

Systemic Mast Cell Disease Associated With the Hypereosinophilic Syndrome

Edwin McElroy, Robert L. Phyliky, Chin‐Yang Li · Mayo Clinic Proceedings · 1998 · 21 citations · Full text

, , +14

Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis

Edwin McElroy, Thomas E. Witzig, Morie A. Gertz et al. · British Journal of Haematology · 1998 · 15 citations · Full text

, , +10

1–5 of 6